Toxicity Study and in silico ADME of some selected Anti-HIV agents inhibitors

S.U Ahanonu¹ , G.A. Shallangwa² , Y.A. Dallatu³ , A. Ibrahim⁴

Section:Research Paper, Product Type: Journal-Paper
Vol.8 , Issue.5 , pp.15-18, Oct-2021

Online published on Oct 31, 2021

Copyright © S.U Ahanonu, G.A. Shallangwa, Y.A. Dallatu, A. Ibrahim . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

Abstract :
Quantitative structural and cytotoxicity relationship (QSCR) has been carried out on twenty pyrindine-4-carboxylate derivatives using genetic function approximation combined with multiple linear regression (GFA-MLR). The following results were obtained by GFA-MLR using three descriptors AATS6i, MAT57e and TDB9s; R-squared, R2 = 0.888666, Adjusted R-squared, R2adj= 0.855266, cross validated R-squared, LOO-Q2CV = 0.710242, Y-randomization, cR2p = 0.793663 and external prediction, R2prediction = 0.8184. Their physiochemical properties are in agreement with a rule given by Lipinski’s rule and results of molecular weight ? 500 daltons, hydrogen acceptors of ? 10, hydrogen bond donors of ? 5 and octanol water partition coefficient ? 5 were obtained. This research provides an understanding on new HIV drugs with reduced toxicity and greater effectiveness.

Key-Words / Index Term :
Anti-HIV agents, Toxicity, Validation, Y- randomization, GFA-MLR

References :
[1]. K. Roy, J. Leonard, “QSAR modelling of HIV-1 reverse transcriptase inhibitor 2-amino-6-arylsulfonylbenzonitriles and congeners using molecular connectivity and t-state parameters, “Bioorg Medicinal. Chemistry, Vol.12, Issue. 4, pp. 745-754, 2004.
[2]. A.S.Ugochukwu, , G. A. Shallangwa, A. Uzairu., “Quantum and statistical study for evaluating the cytotoxicity ability of some pyrazole derivatives as potent Anti HIV-1 agents inhibitors, “International journal of New Chemistry, Vol. 8 Issue. 2, pp. 131-141, 2021.
[3]. F. Ooms, “Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry, “Current medicinal chemistry, Vol. 7 Issue. 2, pp. 141-158, 2000.
[4]. G. Liu, R. Luo, X. ZHANG, Y. ZHOU, J. LI, Y. ZHENG, H. Liu, “Synthesis and Evaluation of Anti-HIV Activities of Novel 7-Hydroxy-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-4-carboxylate Derivatives, “Medicinal chemistry, Vol.4 Issue. 8, pp. 573-580, 2014.
[5]. S.U. Ahanonu, S. U, G. A. Shallangwa, U. Adamu, “Quantitative structure and activity relationship of 3a, 6a – Dihydro-1H- pyrrolo[3,4-c] pyrazole-4,6-dione “Turkish Computational and Theoretical Chemistry, Vol. 4, Issue. 1, pp. 32 – 38, 2020.
[6]. A. Tropsha, “Best practices for QSAR model Development, Validation and Explitation, “Mol. Inf, Vol. 29, Issue. 6, pp. 476-488, 2010.
[7]. K. Roy, “Some aspects of validation of predictive quantitative structure-activity relationship models, “Expert Opinion On Drug Discovery, Vol. 2, Issue. 12, pp. 1567-1577, 2007.
[8]. S. A. Asma, A. S. Hassan, A. M. Naglah, “In vitro cytotoxicity and druglikeness of pyrazolines and pyrindines bearing benzofuran moiety, “Journal of Applied pharmaceutical science, Vol. 10, Issue. 4, pp. 142-148, 2020.
[9]. C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J.Feeney, “Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, “Journal of Advanced Drug Delivery. Reviews, Vol. 46 Issue. 1, pp. 3-26, 2001.